Edwin F. Florencia

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.

Journal: The British journal of dermatology

Published: September 05, 2022

Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa.

Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa.

Journal: The Journal of investigative dermatology

Published: March 09, 2022

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.

Journal: Frontiers in immunology

Published: June 03, 2021

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers.

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers.

Journal: British journal of clinical pharmacology

Published: May 19, 2021

Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.

Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.

Journal: Journal of the American Academy of Dermatology

Published: July 24, 2020

Lesional Inflammatory Profile in Hidradenitis Suppurativa Is Not Solely Driven by IL-1.

Lesional Inflammatory Profile in Hidradenitis Suppurativa Is Not Solely Driven by IL-1.

Journal: The Journal of investigative dermatology

Published: December 15, 2019

Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.

Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.

Journal: Clinical and translational science

Published: July 31, 2019

Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

Journal: Clinical and translational science

Published: March 08, 2017

Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.

Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 08, 2017

MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.

MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.

Journal: The Journal of investigative dermatology

Published: August 11, 2015

IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.

IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 09, 2014

Regulated genes in psoriatic skin during treatment with fumaric acid esters.

Regulated genes in psoriatic skin during treatment with fumaric acid esters.

Journal: The British journal of dermatology

Published: May 14, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026